ASX Notice
Released
Released
Announcement PDF
Notice
Notice reference number: 0675.17.06
Notice date: 21/06/2017
Effective date: 21/06/2017
What’s this about?
ASX Trade
ASX 24
ASX TECH
Trading
Clearing
Settlement
ALC
ASX NET
Technology
Market Data
Rules
Compliance
Operations
Risk
Other
Title
Imagion Biosystems Limited - Admission and Commencement of Official Quotation
Description
1B
Imagion Biosystems Limited (Company) was admitted to the Official List of ASX Limited (ASX) on Wednesday 21 June
2017.
Official quotation of the Company’s securities will commence at 10:30am AEST on Thursday 22 June 2017. The
Company has raised $12,000,000 pursuant to the offer under its replacement prospectus dated 30 May
2017 (Prospectus), by the issue of 60,000,000 ordinary shares each fully paid at an issue price of $0.20 per share.
Quoted securities:
91,232,785 fully paid ordinary shares
ASX code:
IBX
Time:
10:30am AEST
Date:
Thursday 22 June 2017
ASX Trade
IMAGIONBIO
abbreviation:
ISIN:
AU000000IBX6
Home branch:
Melbourne
Industry
3520 - Biotechnology
classification:
Registered office:
Corporate Office:
C/-Holding Redlich
Level 8, 555 Bourke Street
Melbourne VIC 3000
C/- Imagion Biosystems Ltd
800 Bradbury Drive SE # 213
Albuquerque, New Mexico
87106,USA
Phone: +1 505-243-1058
Website:imagionbiosystems.com
Company secretary: Jovanka Naumoska
Share registry:
Boardroom Pty Ltd (NSW)
Balance date:
31 December
CHESS:
Participating. The Company will also operate an issuer sponsored sub-register.
Place of incorporation: Victoria
Dividend policy:
Refer to section 1.4 of the Company’s Prospectus.
Research and development of medical diagnostics, specifically, medical imaging
Activities:
technology.
ASX Restricted
78,099,476 fully paid ordinary shares, classified by ASX as restricted securities to be
securities:
held in escrow for a period of 24 months from the date of official quotation.
1/2
ASX Notice Notice
(continued)
30,950,569 fully paid ordinary shares, classified by ASX as restricted securities to be
held in escrow for a period of 12 months from the date of issue being 7 February
2017.
3,783,333 fully paid ordinary shares, classified by ASX as restricted securities to be
held in escrow for a period of 12 months from the date of issue being 15 June
2017.
9,600,000 performance rights, classified by ASX as restricted securities to be held in
escrow for a period of 24 months from the date of official quotation.
3,400,000 performance rights issued under the Company’s Long Term Incentive
Securities not quoted:
Plan.
Need more information?
For further details, please refer to the Company’s Prospectus.
Issued by
Dean Litis, Principal Adviser, Listings Compliance (Melbourne)
Contact information
(03) 9617 8772
Disclaimer
5
2/2
Share your feedback
Discover